BUL: THQM Statistics

Total Valuation

Tchaikapharma High Quality Medicines AD has a market cap or net worth of BGN 1.64 billion. The enterprise value is 1.65 billion.

Market Cap	1.64B
Enterprise Value	1.65B

Important Dates

The next estimated earnings date is Tuesday, February 25, 2025.

Earnings Date	Feb 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Tchaikapharma High Quality Medicines AD has 91.80 million shares outstanding. The number of shares has decreased by -0.41% in one year.

Current Share Class	n/a
Shares Outstanding	91.80M
Shares Change (YoY)	-0.41%
Shares Change (QoQ)	-6.49%
Owned by Insiders (%)	81.10%
Owned by Institutions (%)	n/a
Float	17.35M

Valuation Ratios

The trailing PE ratio is 492.28.

PE Ratio	492.28
Forward PE	n/a
PS Ratio	31.56
PB Ratio	15.03
P/TBV Ratio	15.53
P/FCF Ratio	1,408.07
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 252.14, with an EV/FCF ratio of 1,417.11.

EV / Earnings	495.44
EV / Sales	33.17
EV / EBITDA	252.14
EV / EBIT	n/a
EV / FCF	1,417.11

Financial Position

The company has a current ratio of 5.90, with a Debt / Equity ratio of 0.10.

Current Ratio	5.90
Quick Ratio	4.48
Debt / Equity	0.10
Debt / EBITDA	1.64
Debt / FCF	9.19
Interest Coverage	6.79

Financial Efficiency

Return on equity (ROE) is 3.10% and return on invested capital (ROIC) is 2.16%.

Return on Equity (ROE)	3.10%
Return on Assets (ROA)	2.07%
Return on Capital (ROIC)	2.16%
Revenue Per Employee	244,363
Profits Per Employee	16,363
Employee Count	191
Asset Turnover	0.40
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+5.29%
50-Day Moving Average	17.46
200-Day Moving Average	16.64
Relative Strength Index (RSI)	62.82
Average Volume (20 Days)	147

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tchaikapharma High Quality Medicines AD had revenue of BGN 49.85 million and earned 3.34 million in profits. Earnings per share was 0.04.

Revenue	49.85M
Gross Profit	50.08M
Operating Income	4.09M
Pretax Income	3.88M
Net Income	3.34M
EBITDA	5.93M
EBIT	4.09M
Earnings Per Share (EPS)	0.04

Full Income Statement

Balance Sheet

The company has 174,000 in cash and 10.72 million in debt, giving a net cash position of -10.55 million or -0.11 per share.

Cash & Cash Equivalents	174,000
Total Debt	10.72M
Net Cash	-10.55M
Net Cash Per Share	-0.11
Equity (Book Value)	109.35M
Book Value Per Share	1.19
Working Capital	68.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.16 million and capital expenditures -1.99 million, giving a free cash flow of 1.17 million.

Operating Cash Flow	3.16M
Capital Expenditures	-1.99M
Free Cash Flow	1.17M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 100.45%, with operating and profit margins of 8.21% and 6.70%.

Gross Margin	100.45%
Operating Margin	8.21%
Pretax Margin	7.78%
Profit Margin	6.70%
EBITDA Margin	11.90%
EBIT Margin	8.21%
FCF Margin	2.34%

Dividends & Yields

Tchaikapharma High Quality Medicines AD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.41%
Shareholder Yield	0.41%
Earnings Yield	0.21%
FCF Yield	0.07%

Stock Splits

The last stock split was on July 3, 2023. It was a forward split with a ratio of 1.0508876.

Last Split Date	Jul 3, 2023
Split Type	Forward
Split Ratio	1.0508876

Scores

Tchaikapharma High Quality Medicines AD has an Altman Z-Score of 59.3.

Altman Z-Score	59.3
Piotroski F-Score	n/a